Treating Multiple Myeloma by Targeting the NF-Kappa-B Pathway with Gadd45-Beta/MKK7 Inhibitors

Wei Gu

HAUSP inhibitors in p53-wild type and p53-mutant tumors

Non-Hodgkin lymphoma Multiple myeloma and immunoproliferative diseases Colorectum

Robert M Williams

Multiple Myeloma and Cancer Therapies via Largazole Analogs

Multiple myeloma and immunoproliferative diseases Leukaemia

Hematology and hematologic malignancies Pathology

William Figg

Using Clinical Pharmacology Principles to Develop New Anticancer Therapies

Thymus Prostate Non-Hodgkin lymphoma Multiple myeloma and immunoproliferative diseases

Hematology and hematologic malignancies Pathology

Nikhil C Munshi

Clinical and Tissue Core

Multiple myeloma and immunoproliferative diseases

Hematology and hematologic malignancies Pathology

Nikhil C Munshi

Genomics Core

Multiple myeloma and immunoproliferative diseases

Hematology and hematologic malignancies Pathology

Multiple Myeloma Study / Histological Classification and Clinical Course of Surface Epithelial Ovarian Tumors in Abuja

Ovary Multiple myeloma and immunoproliferative diseases

Hematology and hematologic malignancies Pathology

Antonio Fojo

Clinical, Basic, Translational and Kinetic Studies of Drug Action and Resistance

Prostate Multiple myeloma and immunoproliferative diseases Breast All cancers but non-melanoma skin cancer

Nathaniel Rothman

DDT, PCBs, and Other Persistent Organohalide Chemicals in the JANUS Cohort

Trachea, bronchus and lung Thyroid Testis Prostate Pancreas Ovary Non-Hodgkin lymphoma Multiple myeloma and immunoproliferative diseases Lip, oral cavity Leukaemia

Hematology and hematologic malignancies Pathology

Kenneth C. Anderson

SPORE in Multiple Myeloma

Multiple myeloma and immunoproliferative diseases